Avioq

The company's current products include FDA-approved HIV-1 tests (Class III devices), FDA-cleared HTLV-I/II tests for screening serum and plasma from blood donors, as well as cadaveric samples, which also bear the CE mark and Health Canada approval. Additionally, three other products with the CE mark include a homogeneous biochemiluminescence-based Flu A/B diagnostic test, a rapid influenza virus resistance test, and an oral fluid collection device. The company has two more HIV products in final development: a 4th generation HIV-1/2/Ag test and an HIV Profile assay to detect and quantify antibody levels against different gene products of HIV-1 and HIV-2. The company also provides contract research, development, and manufacturing services for diagnostic test kits and critical biomaterials for third parties.